Neutralizing activity of therapeutic antibodies against clinical strains of BA.1 and BA.2 sub-lineages of the Omicron variant - News-Medical.Net

Researchers conducted an in vitro analysis to assess the efficacy of monoclonal antibodies against the SARS-CoV-2 Omicron BA.2 and BA.1 variants.

In a recent study posted to the Research Square* preprint server, researchers conducted an in vitro analysis to assess the efficacy of monoclonal antibodies against the severe acute respiratory syndr… [+4914 chars]

full article...